International Conference on Artificial Intelligence in Epilepsy and Neurological Disorders
Breckenridge, CO, USA
7 - 10 March 2023
Over the last few years, there has been a tremendous growth in the use of machine learning and artificial intelligence in a large variety of applications, ranging from social media to everyday applications such as vehicle navigation. With the advent of sophisticated imaging technologies, advanced signal processing, and wearable devices, the focus has shifted to healthcare. There has accordingly been a large increase in interest as well as in research, clinical decision support, and tools that utilize artificial intelligence. Critical assessment of value and utility has lagged behind. We are organizing a conference to address these needs, which is crucial at this juncture, so as to bring knowledge and understanding to the epilepsy community. The program is organized as a current state of the art, which will address a variety of topics assessing the current situations in the field, any progress made, and future directions.
The overarching goal of the International Conference on Artificial Intelligence in Epilepsy and Neurological Disorders is to educate clinicians, researchers, computer scientists, developers and entrepreneurs on the utility and implications of machine learning and artificial intelligence in the field of epilepsy and other neurological disorders in the setting of a state of the art conference. The speakers are all highly regarded experts with interests ranging from epilepsy phenotyping to drug discovery, seizure forecasting and device development.
CME: 17.5 points
Organizing Committee: Sam Lhatoo MD, Michael Sperling MD, Sandor Beniczky MD and Philippe Ryvlin MD
Scientific Committee: Sam Lhatoo MD, Michael Sperling MD, Sandor Beniczky MD and Philippe Ryvlin MD, Daniel Goldenholz MD, GQ Zhang PhD and Sandipan Pati MD
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community